Dysbiosis in the gut microbiota can exacerbate the tumorigenic effects of AIM2 deficiency, highlighting the complex relationship between host genetics, immune responses, and microbial influences in CRC development (74, 75). The gene discussed is AIM2; the disease is colorectal carcinoma.